1
TITLE: Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis  Full Text
AUTHORS: Andre N Abrunhosa Branquinho; Raquel Bar Deroma; Sandra Collette; Enrico Clementel; Yan Liu; Coen W Hurkmans; Loic Feuvret; Karen Van Beek; Martin van den Bent; Brigitta G Baumert; Damien C Weber;
PUBLISHED: 2018, SOURCE: RADIOTHERAPY AND ONCOLOGY, VOLUME: 127, ISSUE: 2
INDEXED IN: Scopus WOS
2
TITLE: EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin  Full Text
AUTHORS: Samantha Cambier; Richard J Sylvester; Laurence Collette; Paolo Gontero; Maurizio A Brausi; George van Andel; Wim J Kirkels; Fernando Calais Da Silva; Willem Oosterlinck; Stephen Prescott; Ziya Kirkali; Philip H Powell; Theo M de Reijke; Levent Turkeri; Sandra Collette; Jorg Oddens;
PUBLISHED: 2016, SOURCE: EUROPEAN UROLOGY, VOLUME: 69, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef